https://t.co/oL3pGiBny2
I do want to talk a bit about connections, conflicts and information during a pandemic. Since @fordnation insinuated I have COI which I don't, let's take a look at a single instance where @fordnation and Hospital for Sick Children are both making interesting decisions.
https://t.co/oL3pGiBny2
https://t.co/DUk89IfHPU
Mary Federau is the Executive Vice President of Mattamy Asset Management, the parent company of Mattamy Homes. Mary plays an integral role in setting direction and execution of the organization's overall strategies for long-term...
She sounds like an impressive and good person. I am absolutely NOT suggesting any misdeeds on her part.
Even more so having learned that Sickkids is pushing public messaging that lockdowns are harming child mental health, while sitting on data showing kids' mental health, according...
Again, I'm not accusing anyone of wrongdoing here. But if we're going to talk about transparency and who funds who, let's all do it, k?
Some very important conflict situations that exist are well known to journalists, and I realize...
More from Health
Now you know I love to sh-t in Harvard. But I also like accuracy. So I decided to go look at Harvard’s catalog to see its lack of military history that this article describes (they only teach history of pets it claims) and what I found shocked me! Shocked me! A thread: 1/
First off, Harvard students literally have multiple sections of military history that they can take listed. (It appears these ones are taught at MIT, so they might have to walk down the street for these) but... 2/
Say they want to stay on campus...they can only take numerous classes on war and diplomacy...3/
They have an entire class on Yalta. That’s right. An entire class on Yalta. 4/
But wait! There is more! They can take the British Empire, The Fall of the Roman Empire for those wanting traditional topics... 5/
\u201cMilitary history\u201d is only in decline if you\u2014like the author & experts in this obnoxious piece\u2014see the subject as a narrowly defined, white dude-oriented, guns & bayonets approach. The field is 1000% better off w/today\u2019s diversity of topics & historians. https://t.co/dUf3OWyVpQ
— Jonathan S. Jones (@_jonathansjones) February 1, 2021
First off, Harvard students literally have multiple sections of military history that they can take listed. (It appears these ones are taught at MIT, so they might have to walk down the street for these) but... 2/
Say they want to stay on campus...they can only take numerous classes on war and diplomacy...3/
They have an entire class on Yalta. That’s right. An entire class on Yalta. 4/
But wait! There is more! They can take the British Empire, The Fall of the Roman Empire for those wanting traditional topics... 5/
This is a limited point about availability of efficacy data for vaccines under development in the context of the approval for CovidShield and Covaxin in India.
There have been many so-called experts on the idiotbox opining about apparent availability of P III data which 1/n
2/n apparently the SEC had access to based on which it "supposedly" approved Covaxin. Another argument that is prevalent is other regulators (US FDA and MHRA) also approved vaccines based on P II data alone. Let me give you a few facts so that you can make your own decision.
3/n The protocols for both mRNA vaccines are publicly available. You can check. Both protocols *define* when the interim analysis will be done. This is not subjective. They clearly define how many infections need to be documented before the Data Safety Monitoring Board meets.
4/n Find the protocols for the bridging study for CovidShield and Covaxin and look for a similar milestone.
Here is one set of efficacy data post the interim analysis of a mRNA vaccine.
Source: https://t.co/BAPnP3PxEb
5/n This data was analyzed post the interim analysis where the blind was broken by the DSMB. Now ask yourself this question:
How does the SEC, or the sponsor of these studies, or the experts who are offering their opinion liberally on the idiotbox know what the efficacy is
There have been many so-called experts on the idiotbox opining about apparent availability of P III data which 1/n
2/n apparently the SEC had access to based on which it "supposedly" approved Covaxin. Another argument that is prevalent is other regulators (US FDA and MHRA) also approved vaccines based on P II data alone. Let me give you a few facts so that you can make your own decision.
3/n The protocols for both mRNA vaccines are publicly available. You can check. Both protocols *define* when the interim analysis will be done. This is not subjective. They clearly define how many infections need to be documented before the Data Safety Monitoring Board meets.
4/n Find the protocols for the bridging study for CovidShield and Covaxin and look for a similar milestone.
Here is one set of efficacy data post the interim analysis of a mRNA vaccine.
Source: https://t.co/BAPnP3PxEb
5/n This data was analyzed post the interim analysis where the blind was broken by the DSMB. Now ask yourself this question:
How does the SEC, or the sponsor of these studies, or the experts who are offering their opinion liberally on the idiotbox know what the efficacy is